Efficacy and safety of fezolinetant, a neurokinin-3 antagonist, in treating vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis
GastroenterologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Medicine
- Publicado em
- 15 dez 2023
- Citações
- 16
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Efficacy and safety of fezolinetant, a neurokinin-3 antagonist, in treating vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis
Ummi Aiman Rahman, Talha Bin Kashif, Muhammad Usman, Maham Rana, Muhammad Hasanain, Muhammad Umair Anjum, Huzaifa Ahmad Cheema, Huda Jaffar, Pratik Bhattarai
Descritores MeSH
- Endometrial Hyperplasia
- Chemical and Drug Induced Liver Injury
- Heterocyclic Compounds, 2-Ring
- Humans
- Menopause
- Quality of Life
- Thiadiazoles
- Uterine Hemorrhage
- Postmenopause
- Hot Flashes
Veja também
Estudos relacionados
- Efficacy and Safety of Fezolinetant for the Treatment of Menopause-Associated Vasomotor Symptoms: A Meta-analysis
- Efficacy and safety of fezolinetant and elinzanetant for vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis
- Effectiveness and safety of fezolinetant in alleviating vasomotor symptoms linked to Menopause.: A systematic review and Meta-Analysis
- Efficacy and safety of fezolinetant for vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials